ALGS vs DAL
Aligos Therapeutics Inc (ALGS) versus Delta Air Lines Inc (DAL) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
ALGS currently screens at market cap $44.1M. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Not investment advice. Open the ALGS and DAL stock pages for the full models.
Not investment advice.